Elias Jabbour, MD, provides an overview of the history of targeted agents and the use of tyrosine kinase inhibitors (TKIs) in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).
Hereditary Ovarian Cancer Genes Found Beyond Traditionally High-Risk Groups
Hereditary ovarian cancer genes occur across diverse populations, supporting inclusive genetic testing.
Read More
Managed Care Cast Presents: New Evidence and Economic Considerations in IPF Care
Experts discuss the clinical and economic burden of idiopathic pulmonary fibrosis (IPF), emerging clinical data, and strategies to improve patient outcomes.
Listen
ACIP Delayed Hepatitis B Vaccine Schedule Vote Amid Safety Controversy
ACIP delayed the vote on the hepatitis B vaccine schedule amid ongoing controversy and misinformation surrounding vaccine safety and infant immunization.
Inside the Discovery That Changed CML Treatment Forever: Jorge Cortes, MD
Lead CML researcher discusses the evolution of a groundbreaking treatment and its effect on patient survival.
Heart Failure Therapies Show Limited Impact in Chagas Disease
Guideline-recommended HF therapies do not improve major outcomes in Chagas disease, though sacubitril/valsartan improved NT-proBNP levels, new data show.
Maintaining Tear Film Stability in Dry Eye Requires Frequent Blinking
New research shows that those with dry eye need more than 20 blinks per minute to maintain their tear film.